4//SEC Filing
Mehalick David 4
Accession 0001683168-23-000432
CIK 0001759186other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 10:59 AM ET
Size
9.3 KB
Accession
0001683168-23-000432
Insider Transaction Report
Form 4
Mehalick David
DirectorCEO and President10% Owner
Transactions
- Award
Incentive Stock Options (right to buy)
2023-01-27+250,000→ 250,000 totalExercise: $1.76→ Common Stock (250,000 underlying) - Award
Non-qualified Stock Options (right to buy)
2023-01-27+375,000→ 375,000 totalExercise: $1.60→ Common Stock (375,000 underlying)
Footnotes (10)
- [F1]On January 27, 2023, the reporting person received a grant of 375,000 stock options, as non-qualified options, under the 2022 equity incentive plan.
- [F10]Following the exercise of options under both reported transactions, the reporting person will have a total of 625,000 derivative securities beneficially owned.
- [F2]On January 27, 2023, the reporting person received a grant of 250,000 incentive stock options, under the 2022 equity incentive plan.
- [F3]Options will vest over 4 years, with the first 25% vesting on 12/31/23, and the balance vesting in equal quarterly installments over the succeeding three years, with the final options vesting on 12/31/26.
- [F4]Options will vest over 4 years, with the first 25% vesting on 12/31/23, and the balance vesting in equal quarterly installments over the succeeding three years, with the final options vesting on 12/31/26.
- [F5]The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant.
- [F6]The exercise price is equal to 110% of the FMV of the shares on the day of grant.
- [F7]Expiration date is ten years from the day of grant
- [F8]Expiration date is five years from the day of grant, as the reporting person is a 10% owner and the options are incentive stock options.
- [F9]Following the exercise of options under both reported transactions, the reporting person will have a total of 625,000 derivative securities beneficially owned.
Documents
Issuer
Coeptis Therapeutics Holdings, Inc.
CIK 0001759186
Entity typeother
Related Parties
1- filerCIK 0001846623
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 10:59 AM ET
- Size
- 9.3 KB